Elsevier Inc.

SHERPA: Unknown

People

  1. Hassoun
    Hassoun
  2. Landau
    Landau
  3. Giralt
    Giralt
  4. Chung
    Chung
  5. Lesokhin
    Lesokhin
  6. Devlin
    Devlin
  7. Landgren
    Landgren
  8. Korde
    Korde
  9. Mailankody
    Mailankody
  10. Shah
    Shah

Groups

  1. Adult Bone Marrow Transplant (BMT) Service (23)
  2. Bone Marrow Transplant (23)
  3. Center for Hematologic Malignancies (23)
  4. Hematologic Oncology, Division of (23)
  5. Myeloma Service (23)
  6. Myeloma (23)
  7. Survivorship Research (23)
  8. Hematologic Malignancies Research (15)
  9. Biostatistics Service (11)
  10. Epidemiology and Biostatistics (11)
Search Within
Refine Results
  1. "Heather Landau"
  2. "Myeloma Service"
Formats
  1. Meeting Abstract (19)
  2. Journal Article (4)
Groups
  1. Adult Bone Marrow Transplant (BMT) Service (23)
  2. Bone Marrow Transplant (23)
  3. Center for Hematologic Malignancies (23)
  4. Hematologic Oncology, Division of (23)
  5. Myeloma (23)
  6. Myeloma Service (23)

More Groups

People
  1. Heather Landau (23)
  2. Hani Hassoun (22)
  3. Sergio Giralt (20)
  4. David Chung (17)
  5. Alexander Lesokhin (15)
  6. Nikoletta Lendvai (14)

More People

Years
  1. 2019 (5)
  2. 2018 (2)
  3. 2017 (3)
  4. 2016 (2)
  5. 2015 (1)
  6. 2014 (3)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (13)
  2. Clinical Lymphoma, Myeloma and Leukemia (9)
  3. Clinical Biochemistry (1)

Results (23)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1/2 study to assess safety and dose of ixazomib in combination with cyclophosphamide and dexamethasone in newly diagnosed patients with light chain (AL) amyloidosis
    Meeting Abstract

    Sanchez, L.; Landau, H.; Rosenbaum, C.; Abrahams, A.; Chin, C.; Liotta, B.; Agudo, N.; Ramnath, S.; Hoover, E.; Rahman, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • BCMA expression in AL Amyloidosis
    Meeting Abstract

    Bal, S.; Sigler, A.; Chan, A.; Chung, D.; Dogan, A.; Giralt, S.; Hassoun, H.; Landau, H.
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Depth of response and outcomes by initial therapy prior to autologous hematopoietic stem cell transplantation for multiple myeloma
    Meeting Abstract

    Shah, G.; Chung, D.; Scordo, M.; Seier, K.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Lesokhin, A.; Mailankody, S.; Shah, U.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Practice patterns with focal progression on daratumumab therapy
    Meeting Abstract

    Bal, S.; Peterson, T.; Landau, H.; Chung, D.; Giralt, S.; Korde, N.; Mailankody, S.; Smith, E.; Shah, U.; Hultcrantz, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Stem cell mobilization and autograft purity with novel induction regimens in multiple myeloma
    Meeting Abstract

    Bal, S.; Landau, H.; Shah, G.; Scordo, M.; Dahi, P.; Lahoud, O.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Lesokhin, A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Revaccination after autologous hematopoietic stem cell transplantation is safe and effective in patients with multiple myeloma receiving lenalidomide maintenance
    Journal Article

    Palazzo, M.; Shah, G. L.; Copelan, O.; Seier, K.; Devlin, S. M.; Maloy, M.; Kenny, S.; Hassoun, H.; Korde, N. S.; Lendvai, N.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Treatment of multiple myeloma with monoclonal antibodies and the dilemma of false positive M-spikes in peripheral blood
    Journal Article

    Murata, K.; McCash, S. I.; Carroll, B.; Lesokhin, A. M.; Hassoun, H.; Lendvai, N.; Korde, N. S.; Mailankody, S.; Landau, H. J.; Koehne, G.; more...
    Clinical Biochemistry (2018)

    Fulltext@MSK | Save
  • Galinpepimut-S, a WT1-targeting immuno-oncology treatment, induces specific, robust and durable immune responses (IRs) in patients (Pts) with high-risk (HR) multiple myeloma (MM)
    Meeting Abstract

    Koehne, G.; Devlin, S.; Korde, N.; Mailankody, S.; Heather, L.; Hassoun, H.; Lesokhin, A.; Lendvai, N.; Chung, D.; Sarlis, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Improvement of response for multiple myeloma patients on lenalidomide maintenance after autologous hematopoietic stem cell transplantation (Auto HCT)
    Meeting Abstract

    Shah, G.; Assal, A.; Hsu, M.; Devlin, S.; Hassoun, H.; Korde, N.; Lendvai, N.; Lesokhin, A.; Mailankody, S.; Smith, E.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Re-immunization following autologous hematopoietic stem cell transplantation (Auto HCT) is safe and effective in patients with multiple myeloma receiving lenalidomide maintenance
    Meeting Abstract

    Shah, G.; Palazzo, M.; Copelan, O.; Seier, K.; Devlin, S.; Hassoun, H.; Korde, N.; Lendvai, N.; Lesokhin, A.; Mailankody, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save